213 related articles for article (PubMed ID: 23909664)
1. Design, synthesis, and mechanistic investigations of bile acid-tamoxifen conjugates for breast cancer therapy.
Sreekanth V; Bansal S; Motiani RK; Kundu S; Muppu SK; Majumdar TD; Panjamurthy K; Sengupta S; Bajaj A
Bioconjug Chem; 2013 Sep; 24(9):1468-84. PubMed ID: 23909664
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence (fluidity/hydration) and calorimetric studies of interactions of bile acid-drug conjugates with model membranes.
Sreekanth V; Bajaj A
J Phys Chem B; 2013 Feb; 117(7):2123-33. PubMed ID: 23383746
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL; Wang JY; Tsai YF; Lin YH; Tseng LM; Chang WC; King KL; Chen WS; Chiu JH; Shyr YM
Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
[TBL] [Abstract][Full Text] [Related]
4. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
[TBL] [Abstract][Full Text] [Related]
6. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
Vessières A; Corbet C; Heldt JM; Lories N; Jouy N; Laïos I; Leclercq G; Jaouen G; Toillon RA
J Inorg Biochem; 2010 May; 104(5):503-11. PubMed ID: 20116857
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.
Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R
J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032
[TBL] [Abstract][Full Text] [Related]
8. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of targeted dibenzo[b,f]thiepines and dibenzo[b,f]oxepines as potential lead molecules with promising anti-breast cancer activity.
Ansari MI; Hussain MK; Arun A; Chakravarti B; Konwar R; Hajela K
Eur J Med Chem; 2015 Jun; 99():113-24. PubMed ID: 26067208
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
Burke PJ; Koch TH
J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
[TBL] [Abstract][Full Text] [Related]
11. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
12. Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies.
Agarwal DS; Siva Krishna V; Sriram D; Yogeeswari P; Sakhuja R
Steroids; 2018 Nov; 139():35-44. PubMed ID: 30236620
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
[TBL] [Abstract][Full Text] [Related]
14. Tethering of Chemotherapeutic Drug/Imaging Agent to Bile Acid-Phospholipid Increases the Efficacy and Bioavailability with Reduced Hepatotoxicity.
Sreekanth V; Medatwal N; Kumar S; Pal S; Vamshikrishna M; Kar A; Bhargava P; Naaz A; Kumar N; Sengupta S; Bajaj A
Bioconjug Chem; 2017 Dec; 28(12):2942-2953. PubMed ID: 29083862
[TBL] [Abstract][Full Text] [Related]
15. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
Zavodovskaya M; Campbell MJ; Maddux BA; Shiry L; Allan G; Hodges L; Kushner P; Kerner JA; Youngren JF; Goldfine ID
J Cell Biochem; 2008 Feb; 103(2):624-35. PubMed ID: 17562544
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.
Cover CM; Hsieh SJ; Cram EJ; Hong C; Riby JE; Bjeldanes LF; Firestone GL
Cancer Res; 1999 Mar; 59(6):1244-51. PubMed ID: 10096555
[TBL] [Abstract][Full Text] [Related]
17. Number of free hydroxyl groups on bile acid phospholipids determines the fluidity and hydration of model membranes.
Sreekanth V; Bajaj A
J Phys Chem B; 2013 Oct; 117(40):12135-44. PubMed ID: 24079709
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen peroxide overproduced in breast cancer cells can serve as an anticancer prodrug generating apoptosis-stimulating hydroxyl radicals under the effect of tamoxifen-ferrocene conjugate.
Wlassoff WA; Albright CD; Sivashinski MS; Ivanova A; Appelbaum JG; Salganik RI
J Pharm Pharmacol; 2007 Nov; 59(11):1549-53. PubMed ID: 17976267
[TBL] [Abstract][Full Text] [Related]
19. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
20. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
